Disease-Modifying Antirheumatic Drugs Increase Serum Adiponectin Levels in Patients With Rheumatoid Arthritis

Cansu B., ÜSKÜDAR CANSU D., KAŞİFOĞLU T., Gulbas Z., KORKMAZ C.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, cilt.17, sa.1, ss.14-17, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 1
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1097/rhu.0b013e318204a587
  • Dergi Adı: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.14-17
  • Anahtar Kelimeler: adiponectin, acute-phase-response reactants, rheumatoid arthritis, disease activity, INSULIN-RESISTANCE, RISK, LEPTIN
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Background: Adiponectin is an adipocyte-derived adipokine with immunosuppressive and anti-inflammatory properties. It also decreases expression of adhesion molecules. In terms of its relationship with acute-phase reactants, there are conflicting results in patients with rheumatoid arthritis (RA).